pioglitazone has been researched along with phenanthrenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avenia, N; Bonafé, M; Ceccarelli, C; De Carolis, S; Guarnieri, T; Orlandi, M; Papi, A; Sanguinetti, A; Santini, D; Sidoni, A; Storci, G; Taffurelli, M | 1 |
| Bertoni, S; Bonafé, M; Ceccarelli, C; De Carolis, S; Orlandi, M; Papi, A; Santini, D; Sceberras, V; Storci, G; Taffurelli, M | 1 |
2 other study(ies) available for pioglitazone and phenanthrenes
| Article | Year |
|---|---|
Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Humans; Inflammation; Interleukin-6; Neoplastic Stem Cells; NF-kappa B; Phenanthrenes; Pioglitazone; PPAR gamma; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Thiazolidinediones; Tretinoin | 2012 |
PPARγ and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche.
Topics: Antigens, Neoplasm; Apolipoproteins E; Biomarkers, Tumor; Breast Neoplasms; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxia; Cell Survival; Exosomes; Female; Fibroblasts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Ligands; Matrix Metalloproteinase 9; MCF-7 Cells; Models, Biological; Neoplastic Stem Cells; NF-kappa B; Phenanthrenes; Pioglitazone; PPAR gamma; Receptor Cross-Talk; Retinoid X Receptors; Spheroids, Cellular; Stem Cell Niche; Stromal Cells; Thiazolidinediones | 2014 |